170.27
+4.46
+(2.69%)
At close: April 17 at 7:08:28 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 13 | 13 | 17 | 18 |
Avg. Estimate | 975.5M | 1.05B | 4.09B | 4.37B |
Low Estimate | 967.11M | 1.03B | 4.02B | 4.14B |
High Estimate | 985M | 1.08B | 4.16B | 4.84B |
Year Ago Sales | 997.43M | 1.03B | 4B | 4.09B |
Sales Growth (year/est) | -2.20% | 2.55% | 2.33% | 6.72% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HCK.L | -- | -- | -- | -- |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
Maintains | Mizuho: Outperform to Outperform | 3/25/2025 |
Reiterates | Piper Sandler: Overweight to Overweight | 3/18/2025 |
Initiated | Wells Fargo: Overweight | 2/14/2025 |
Maintains | Evercore ISI Group: Outperform to Outperform | 2/6/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 2/6/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 2/6/2025 |